Global Morphine Sulfate Market Growth 2026-2032

Product Code: 2020307

Industry: Pharma & Healthcare

Published: Jul 10,2026

Pages: 142

Delivery Time: 2-3 business days

Global Morphine Sulfate Market Growth 2026-2032

Product Code: 2020307

Industry: Pharma & Healthcare

Published: Jul 10,2026

Pages: 142

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Morphine Sulfate market size is predicted to grow from US$ 3228 million in 2025 to US$ 4107 million in 2032; it is expected to grow at a CAGR of 3.5% from 2026 to 2032.

In 2025, global Morphine Sulfate output reached about 11 billion dosage units and global capacity of around 12 billion dosage units. The average price is about USD 0.30 per dosage unit, with gross margins near 45%. Morphine Sulfate is a pharmaceutical-grade opioid analgesic produced by converting morphine base into its sulfate salt to improve stability, solubility, and suitability for oral, injectable, and controlled-release dosage forms. It is one of the most widely used strong opioid medications for the management of moderate to severe acute and chronic pain, postoperative pain, cancer pain, trauma, myocardial infarction-related pain, and palliative or end-of-life care. Morphine sulfate acts primarily as a μ-opioid receptor agonist within the central nervous system, producing potent analgesic effects while also causing sedation, respiratory depression, and other opioid-related effects. The supply chain begins upstream with the cultivation of opium poppies (Papaver somniferum) under strict government regulation, extraction of opium alkaloids, purification of morphine base, production of pharmaceutical-grade morphine sulfate active pharmaceutical ingredient (API), and sourcing of pharmaceutical excipients, sterile solvents, packaging materials, and quality-control reagents. Midstream activities include API manufacturing, formulation into tablets, oral solutions, injections, sustained-release capsules, and extended-release tablets, followed by sterile filling, packaging, regulatory compliance, and distribution through licensed pharmaceutical wholesalers. Downstream, morphine sulfate is supplied to hospitals, surgical centers, oncology clinics, hospices, emergency medical services, retail and specialty pharmacies, long-term care facilities, military and disaster medicine organizations, and home healthcare providers, where its use is tightly regulated under national controlled-substance legislation to ensure secure handling, traceability, and appropriate clinical use.

United States market for Morphine Sulfate is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Morphine Sulfate is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Morphine Sulfate is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Morphine Sulfate players cover Jiangsu Nhwa Pharmaceutical, Humanwell Healthcare Group, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals, Viatris, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Morphine Sulfate Industry Forecast” looks at past sales and reviews total world Morphine Sulfate sales in 2025, providing a comprehensive analysis by region and market sector of projected Morphine Sulfate sales for 2026 through 2032. With Morphine Sulfate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Morphine Sulfate industry.

This Insight Report provides a comprehensive analysis of the global Morphine Sulfate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Morphine Sulfate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Morphine Sulfate market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Morphine Sulfate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Morphine Sulfate.

This report presents a comprehensive overview, market shares, and growth opportunities of Morphine Sulfate market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Immediate-Release (IR)
    Controlled-Release (CR)
    Sustained-Release (SR)

Segmentation by Strength:
    <15 mg
    15–30 mg
    30–60 mg
    60–100 mg
    >100 mg

Segmentation by Application:
    Acute Pain Management
    Chronic Pain Management

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Jiangsu Nhwa Pharmaceutical
    Humanwell Healthcare Group
    Mallinckrodt Pharmaceuticals
    Hikma Pharmaceuticals
    Viatris
    Pfizer
    Fresenius Kabi
    Hameln Pharma
    Teva Pharmaceutical
    Sun Pharmaceutical
    Amneal Pharmaceuticals
    Rhodes Pharmaceuticals
    Purdue Pharma
    Sandoz
    Alcaliber
    Tasmanian Alkaloids
    G.L. Pharma
    Martindale Pharma

Key Questions Addressed in this Report
What is the 10-year outlook for the global Morphine Sulfate market?
What factors are driving Morphine Sulfate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Morphine Sulfate market opportunities vary by end market size?
How does Morphine Sulfate break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Morphine Sulfate Annual Sales 2021-2032
        2.1.2 World Current & Future Analysis for Morphine Sulfate by Geographic Region, 2021, 2025 & 2032
        2.1.3 World Current & Future Analysis for Morphine Sulfate by Country/Region, 2021, 2025 & 2032
    2.2 Morphine Sulfate Segment by Type
        2.2.1 Immediate-Release (IR)
        2.2.2 Controlled-Release (CR)
        2.2.3 Sustained-Release (SR)
        2.2.4 Morphine Sulfate Sales by Type
            2.2.4.1 Global Morphine Sulfate Sales Market Share by Type (2021-2026)
            2.2.4.2 Global Morphine Sulfate Revenue and Market Share by Type (2021-2026)
            2.2.4.3 Global Morphine Sulfate Sale Price by Type (2021-2026)
    2.3 Morphine Sulfate Segment by Strength
        2.3.1 <15 mg
        2.3.2 15–30 mg
        2.3.3 30–60 mg
        2.3.4 60–100 mg
        2.3.5 >100 mg
        2.3.6 Morphine Sulfate Sales by Strength
            2.3.6.1 Global Morphine Sulfate Sales Market Share by Strength (2021-2026)
            2.3.6.2 Global Morphine Sulfate Revenue and Market Share by Strength (2021-2026)
            2.3.6.3 Global Morphine Sulfate Sale Price by Strength (2021-2026)
    2.4 Morphine Sulfate Segment by Application
        2.4.1 Acute Pain Management
        2.4.2 Chronic Pain Management
        2.4.3 Morphine Sulfate Sales by Application
            2.4.3.1 Global Morphine Sulfate Sale Market Share by Application (2021-2026)
            2.4.3.2 Global Morphine Sulfate Revenue and Market Share by Application (2021-2026)
            2.4.3.3 Global Morphine Sulfate Sale Price by Application (2021-2026)

3 Global by Company
    3.1 Global Morphine Sulfate Breakdown Data by Company
        3.1.1 Global Morphine Sulfate Annual Sales by Company (2021-2026)
        3.1.2 Global Morphine Sulfate Sales Market Share by Company (2021-2026)
    3.2 Global Morphine Sulfate Annual Revenue by Company (2021-2026)
        3.2.1 Global Morphine Sulfate Revenue by Company (2021-2026)
        3.2.2 Global Morphine Sulfate Revenue Market Share by Company (2021-2026)
    3.3 Global Morphine Sulfate Sale Price by Company
    3.4 Key Manufacturers Morphine Sulfate Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Morphine Sulfate Product Location Distribution
        3.4.2 Players Morphine Sulfate Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Morphine Sulfate by Geographic Region
    4.1 World Historic Morphine Sulfate Market Size by Geographic Region (2021-2026)
        4.1.1 Global Morphine Sulfate Annual Sales by Geographic Region (2021-2026)
        4.1.2 Global Morphine Sulfate Annual Revenue by Geographic Region (2021-2026)
    4.2 World Historic Morphine Sulfate Market Size by Country/Region (2021-2026)
        4.2.1 Global Morphine Sulfate Annual Sales by Country/Region (2021-2026)
        4.2.2 Global Morphine Sulfate Annual Revenue by Country/Region (2021-2026)
    4.3 Americas Morphine Sulfate Sales Growth
    4.4 APAC Morphine Sulfate Sales Growth
    4.5 Europe Morphine Sulfate Sales Growth
    4.6 Middle East & Africa Morphine Sulfate Sales Growth

5 Americas
    5.1 Americas Morphine Sulfate Sales by Country
        5.1.1 Americas Morphine Sulfate Sales by Country (2021-2026)
        5.1.2 Americas Morphine Sulfate Revenue by Country (2021-2026)
    5.2 Americas Morphine Sulfate Sales by Type (2021-2026)
    5.3 Americas Morphine Sulfate Sales by Application (2021-2026)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Morphine Sulfate Sales by Region
        6.1.1 APAC Morphine Sulfate Sales by Region (2021-2026)
        6.1.2 APAC Morphine Sulfate Revenue by Region (2021-2026)
    6.2 APAC Morphine Sulfate Sales by Type (2021-2026)
    6.3 APAC Morphine Sulfate Sales by Application (2021-2026)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Morphine Sulfate by Country
        7.1.1 Europe Morphine Sulfate Sales by Country (2021-2026)
        7.1.2 Europe Morphine Sulfate Revenue by Country (2021-2026)
    7.2 Europe Morphine Sulfate Sales by Type (2021-2026)
    7.3 Europe Morphine Sulfate Sales by Application (2021-2026)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Morphine Sulfate by Country
        8.1.1 Middle East & Africa Morphine Sulfate Sales by Country (2021-2026)
        8.1.2 Middle East & Africa Morphine Sulfate Revenue by Country (2021-2026)
    8.2 Middle East & Africa Morphine Sulfate Sales by Type (2021-2026)
    8.3 Middle East & Africa Morphine Sulfate Sales by Application (2021-2026)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Morphine Sulfate
    10.3 Manufacturing Process Analysis of Morphine Sulfate
    10.4 Industry Chain Structure of Morphine Sulfate

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Morphine Sulfate Distributors
    11.3 Morphine Sulfate Customer

12 World Forecast Review for Morphine Sulfate by Geographic Region
    12.1 Global Morphine Sulfate Market Size Forecast by Region
        12.1.1 Global Morphine Sulfate Forecast by Region (2027-2032)
        12.1.2 Global Morphine Sulfate Annual Revenue Forecast by Region (2027-2032)
    12.2 Americas Forecast by Country (2027-2032)
    12.3 APAC Forecast by Region (2027-2032)
    12.4 Europe Forecast by Country (2027-2032)
    12.5 Middle East & Africa Forecast by Country (2027-2032)
    12.6 Global Morphine Sulfate Forecast by Type (2027-2032)
    12.7 Global Morphine Sulfate Forecast by Application (2027-2032)

13 Key Players Analysis
    13.1 Jiangsu Nhwa Pharmaceutical
        13.1.1 Jiangsu Nhwa Pharmaceutical Company Information
        13.1.2 Jiangsu Nhwa Pharmaceutical Morphine Sulfate Product Portfolios and Specifications
        13.1.3 Jiangsu Nhwa Pharmaceutical Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.1.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
        13.1.5 Jiangsu Nhwa Pharmaceutical Latest Developments
    13.2 Humanwell Healthcare Group
        13.2.1 Humanwell Healthcare Group Company Information
        13.2.2 Humanwell Healthcare Group Morphine Sulfate Product Portfolios and Specifications
        13.2.3 Humanwell Healthcare Group Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.2.4 Humanwell Healthcare Group Main Business Overview
        13.2.5 Humanwell Healthcare Group Latest Developments
    13.3 Mallinckrodt Pharmaceuticals
        13.3.1 Mallinckrodt Pharmaceuticals Company Information
        13.3.2 Mallinckrodt Pharmaceuticals Morphine Sulfate Product Portfolios and Specifications
        13.3.3 Mallinckrodt Pharmaceuticals Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.3.4 Mallinckrodt Pharmaceuticals Main Business Overview
        13.3.5 Mallinckrodt Pharmaceuticals Latest Developments
    13.4 Hikma Pharmaceuticals
        13.4.1 Hikma Pharmaceuticals Company Information
        13.4.2 Hikma Pharmaceuticals Morphine Sulfate Product Portfolios and Specifications
        13.4.3 Hikma Pharmaceuticals Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.4.4 Hikma Pharmaceuticals Main Business Overview
        13.4.5 Hikma Pharmaceuticals Latest Developments
    13.5 Viatris
        13.5.1 Viatris Company Information
        13.5.2 Viatris Morphine Sulfate Product Portfolios and Specifications
        13.5.3 Viatris Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.5.4 Viatris Main Business Overview
        13.5.5 Viatris Latest Developments
    13.6 Pfizer
        13.6.1 Pfizer Company Information
        13.6.2 Pfizer Morphine Sulfate Product Portfolios and Specifications
        13.6.3 Pfizer Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.6.4 Pfizer Main Business Overview
        13.6.5 Pfizer Latest Developments
    13.7 Fresenius Kabi
        13.7.1 Fresenius Kabi Company Information
        13.7.2 Fresenius Kabi Morphine Sulfate Product Portfolios and Specifications
        13.7.3 Fresenius Kabi Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.7.4 Fresenius Kabi Main Business Overview
        13.7.5 Fresenius Kabi Latest Developments
    13.8 Hameln Pharma
        13.8.1 Hameln Pharma Company Information
        13.8.2 Hameln Pharma Morphine Sulfate Product Portfolios and Specifications
        13.8.3 Hameln Pharma Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.8.4 Hameln Pharma Main Business Overview
        13.8.5 Hameln Pharma Latest Developments
    13.9 Teva Pharmaceutical
        13.9.1 Teva Pharmaceutical Company Information
        13.9.2 Teva Pharmaceutical Morphine Sulfate Product Portfolios and Specifications
        13.9.3 Teva Pharmaceutical Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.9.4 Teva Pharmaceutical Main Business Overview
        13.9.5 Teva Pharmaceutical Latest Developments
    13.10 Sun Pharmaceutical
        13.10.1 Sun Pharmaceutical Company Information
        13.10.2 Sun Pharmaceutical Morphine Sulfate Product Portfolios and Specifications
        13.10.3 Sun Pharmaceutical Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.10.4 Sun Pharmaceutical Main Business Overview
        13.10.5 Sun Pharmaceutical Latest Developments
    13.11 Amneal Pharmaceuticals
        13.11.1 Amneal Pharmaceuticals Company Information
        13.11.2 Amneal Pharmaceuticals Morphine Sulfate Product Portfolios and Specifications
        13.11.3 Amneal Pharmaceuticals Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.11.4 Amneal Pharmaceuticals Main Business Overview
        13.11.5 Amneal Pharmaceuticals Latest Developments
    13.12 Rhodes Pharmaceuticals
        13.12.1 Rhodes Pharmaceuticals Company Information
        13.12.2 Rhodes Pharmaceuticals Morphine Sulfate Product Portfolios and Specifications
        13.12.3 Rhodes Pharmaceuticals Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.12.4 Rhodes Pharmaceuticals Main Business Overview
        13.12.5 Rhodes Pharmaceuticals Latest Developments
    13.13 Purdue Pharma
        13.13.1 Purdue Pharma Company Information
        13.13.2 Purdue Pharma Morphine Sulfate Product Portfolios and Specifications
        13.13.3 Purdue Pharma Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.13.4 Purdue Pharma Main Business Overview
        13.13.5 Purdue Pharma Latest Developments
    13.14 Sandoz
        13.14.1 Sandoz Company Information
        13.14.2 Sandoz Morphine Sulfate Product Portfolios and Specifications
        13.14.3 Sandoz Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.14.4 Sandoz Main Business Overview
        13.14.5 Sandoz Latest Developments
    13.15 Alcaliber
        13.15.1 Alcaliber Company Information
        13.15.2 Alcaliber Morphine Sulfate Product Portfolios and Specifications
        13.15.3 Alcaliber Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.15.4 Alcaliber Main Business Overview
        13.15.5 Alcaliber Latest Developments
    13.16 Tasmanian Alkaloids
        13.16.1 Tasmanian Alkaloids Company Information
        13.16.2 Tasmanian Alkaloids Morphine Sulfate Product Portfolios and Specifications
        13.16.3 Tasmanian Alkaloids Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.16.4 Tasmanian Alkaloids Main Business Overview
        13.16.5 Tasmanian Alkaloids Latest Developments
    13.17 G.L. Pharma
        13.17.1 G.L. Pharma Company Information
        13.17.2 G.L. Pharma Morphine Sulfate Product Portfolios and Specifications
        13.17.3 G.L. Pharma Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.17.4 G.L. Pharma Main Business Overview
        13.17.5 G.L. Pharma Latest Developments
    13.18 Martindale Pharma
        13.18.1 Martindale Pharma Company Information
        13.18.2 Martindale Pharma Morphine Sulfate Product Portfolios and Specifications
        13.18.3 Martindale Pharma Morphine Sulfate Sales, Revenue, Price and Gross Margin (2021-2026)
        13.18.4 Martindale Pharma Main Business Overview
        13.18.5 Martindale Pharma Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Morphine Sulfate Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
 Table 2. Morphine Sulfate Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
 Table 3. Major Players of Immediate-Release (IR)
 Table 4. Major Players of Controlled-Release (CR)
 Table 5. Major Players of Sustained-Release (SR)
 Table 6. Global Morphine Sulfate Sales by Type (2021-2026) & (K Units)
 Table 7. Global Morphine Sulfate Sales Market Share by Type (2021-2026)
 Table 8. Global Morphine Sulfate Revenue by Type (2021-2026) & ($ million)
 Table 9. Global Morphine Sulfate Revenue Market Share by Type (2021-2026)
 Table 10. Global Morphine Sulfate Sale Price by Type (2021-2026) & (US$/Unit)
 Table 11. Major Players of <15 mg
 Table 12. Major Players of 15–30 mg
 Table 13. Major Players of 30–60 mg
 Table 14. Major Players of 60–100 mg
 Table 15. Major Players of >100 mg
 Table 16. Global Morphine Sulfate Sales by Strength (2021-2026) & (K Units)
 Table 17. Global Morphine Sulfate Sales Market Share by Strength (2021-2026)
 Table 18. Global Morphine Sulfate Revenue by Strength (2021-2026) & ($ million)
 Table 19. Global Morphine Sulfate Revenue Market Share by Strength (2021-2026)
 Table 20. Global Morphine Sulfate Sale Price by Strength (2021-2026) & (US$/Unit)
 Table 21. Global Morphine Sulfate Sale by Application (2021-2026) & (K Units)
 Table 22. Global Morphine Sulfate Sale Market Share by Application (2021-2026)
 Table 23. Global Morphine Sulfate Revenue by Application (2021-2026) & ($ million)
 Table 24. Global Morphine Sulfate Revenue Market Share by Application (2021-2026)
 Table 25. Global Morphine Sulfate Sale Price by Application (2021-2026) & (US$/Unit)
 Table 26. Global Morphine Sulfate Sales by Company (2021-2026) & (K Units)
 Table 27. Global Morphine Sulfate Sales Market Share by Company (2021-2026)
 Table 28. Global Morphine Sulfate Revenue by Company (2021-2026) & ($ millions)
 Table 29. Global Morphine Sulfate Revenue Market Share by Company (2021-2026)
 Table 30. Global Morphine Sulfate Sale Price by Company (2021-2026) & (US$/Unit)
 Table 31. Key Manufacturers Morphine Sulfate Producing Area Distribution and Sales Area
 Table 32. Players Morphine Sulfate Products Offered
 Table 33. Morphine Sulfate Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
 Table 34. New Products and Potential Entrants
 Table 35. Market M&A Activity & Strategy
 Table 36. Global Morphine Sulfate Sales by Geographic Region (2021-2026) & (K Units)
 Table 37. Global Morphine Sulfate Sales Market Share Geographic Region (2021-2026)
 Table 38. Global Morphine Sulfate Revenue by Geographic Region (2021-2026) & ($ millions)
 Table 39. Global Morphine Sulfate Revenue Market Share by Geographic Region (2021-2026)
 Table 40. Global Morphine Sulfate Sales by Country/Region (2021-2026) & (K Units)
 Table 41. Global Morphine Sulfate Sales Market Share by Country/Region (2021-2026)
 Table 42. Global Morphine Sulfate Revenue by Country/Region (2021-2026) & ($ millions)
 Table 43. Global Morphine Sulfate Revenue Market Share by Country/Region (2021-2026)
 Table 44. Americas Morphine Sulfate Sales by Country (2021-2026) & (K Units)
 Table 45. Americas Morphine Sulfate Sales Market Share by Country (2021-2026)
 Table 46. Americas Morphine Sulfate Revenue by Country (2021-2026) & ($ millions)
 Table 47. Americas Morphine Sulfate Sales by Type (2021-2026) & (K Units)
 Table 48. Americas Morphine Sulfate Sales by Application (2021-2026) & (K Units)
 Table 49. APAC Morphine Sulfate Sales by Region (2021-2026) & (K Units)
 Table 50. APAC Morphine Sulfate Sales Market Share by Region (2021-2026)
 Table 51. APAC Morphine Sulfate Revenue by Region (2021-2026) & ($ millions)
 Table 52. APAC Morphine Sulfate Sales by Type (2021-2026) & (K Units)
 Table 53. APAC Morphine Sulfate Sales by Application (2021-2026) & (K Units)
 Table 54. Europe Morphine Sulfate Sales by Country (2021-2026) & (K Units)
 Table 55. Europe Morphine Sulfate Revenue by Country (2021-2026) & ($ millions)
 Table 56. Europe Morphine Sulfate Sales by Type (2021-2026) & (K Units)
 Table 57. Europe Morphine Sulfate Sales by Application (2021-2026) & (K Units)
 Table 58. Middle East & Africa Morphine Sulfate Sales by Country (2021-2026) & (K Units)
 Table 59. Middle East & Africa Morphine Sulfate Revenue Market Share by Country (2021-2026)
 Table 60. Middle East & Africa Morphine Sulfate Sales by Type (2021-2026) & (K Units)
 Table 61. Middle East & Africa Morphine Sulfate Sales by Application (2021-2026) & (K Units)
 Table 62. Key Market Drivers & Growth Opportunities of Morphine Sulfate
 Table 63. Key Market Challenges & Risks of Morphine Sulfate
 Table 64. Key Industry Trends of Morphine Sulfate
 Table 65. Morphine Sulfate Raw Material
 Table 66. Key Suppliers of Raw Materials
 Table 67. Morphine Sulfate Distributors List
 Table 68. Morphine Sulfate Customer List
 Table 69. Global Morphine Sulfate Sales Forecast by Region (2027-2032) & (K Units)
 Table 70. Global Morphine Sulfate Revenue Forecast by Region (2027-2032) & ($ millions)
 Table 71. Americas Morphine Sulfate Sales Forecast by Country (2027-2032) & (K Units)
 Table 72. Americas Morphine Sulfate Annual Revenue Forecast by Country (2027-2032) & ($ millions)
 Table 73. APAC Morphine Sulfate Sales Forecast by Region (2027-2032) & (K Units)
 Table 74. APAC Morphine Sulfate Annual Revenue Forecast by Region (2027-2032) & ($ millions)
 Table 75. Europe Morphine Sulfate Sales Forecast by Country (2027-2032) & (K Units)
 Table 76. Europe Morphine Sulfate Revenue Forecast by Country (2027-2032) & ($ millions)
 Table 77. Middle East & Africa Morphine Sulfate Sales Forecast by Country (2027-2032) & (K Units)
 Table 78. Middle East & Africa Morphine Sulfate Revenue Forecast by Country (2027-2032) & ($ millions)
 Table 79. Global Morphine Sulfate Sales Forecast by Type (2027-2032) & (K Units)
 Table 80. Global Morphine Sulfate Revenue Forecast by Type (2027-2032) & ($ millions)
 Table 81. Global Morphine Sulfate Sales Forecast by Application (2027-2032) & (K Units)
 Table 82. Global Morphine Sulfate Revenue Forecast by Application (2027-2032) & ($ millions)
 Table 83. Jiangsu Nhwa Pharmaceutical Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 84. Jiangsu Nhwa Pharmaceutical Morphine Sulfate Product Portfolios and Specifications
 Table 85. Jiangsu Nhwa Pharmaceutical Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 86. Jiangsu Nhwa Pharmaceutical Main Business
 Table 87. Jiangsu Nhwa Pharmaceutical Latest Developments
 Table 88. Humanwell Healthcare Group Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 89. Humanwell Healthcare Group Morphine Sulfate Product Portfolios and Specifications
 Table 90. Humanwell Healthcare Group Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 91. Humanwell Healthcare Group Main Business
 Table 92. Humanwell Healthcare Group Latest Developments
 Table 93. Mallinckrodt Pharmaceuticals Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 94. Mallinckrodt Pharmaceuticals Morphine Sulfate Product Portfolios and Specifications
 Table 95. Mallinckrodt Pharmaceuticals Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 96. Mallinckrodt Pharmaceuticals Main Business
 Table 97. Mallinckrodt Pharmaceuticals Latest Developments
 Table 98. Hikma Pharmaceuticals Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 99. Hikma Pharmaceuticals Morphine Sulfate Product Portfolios and Specifications
 Table 100. Hikma Pharmaceuticals Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 101. Hikma Pharmaceuticals Main Business
 Table 102. Hikma Pharmaceuticals Latest Developments
 Table 103. Viatris Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 104. Viatris Morphine Sulfate Product Portfolios and Specifications
 Table 105. Viatris Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 106. Viatris Main Business
 Table 107. Viatris Latest Developments
 Table 108. Pfizer Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 109. Pfizer Morphine Sulfate Product Portfolios and Specifications
 Table 110. Pfizer Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 111. Pfizer Main Business
 Table 112. Pfizer Latest Developments
 Table 113. Fresenius Kabi Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 114. Fresenius Kabi Morphine Sulfate Product Portfolios and Specifications
 Table 115. Fresenius Kabi Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 116. Fresenius Kabi Main Business
 Table 117. Fresenius Kabi Latest Developments
 Table 118. Hameln Pharma Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 119. Hameln Pharma Morphine Sulfate Product Portfolios and Specifications
 Table 120. Hameln Pharma Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 121. Hameln Pharma Main Business
 Table 122. Hameln Pharma Latest Developments
 Table 123. Teva Pharmaceutical Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 124. Teva Pharmaceutical Morphine Sulfate Product Portfolios and Specifications
 Table 125. Teva Pharmaceutical Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 126. Teva Pharmaceutical Main Business
 Table 127. Teva Pharmaceutical Latest Developments
 Table 128. Sun Pharmaceutical Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 129. Sun Pharmaceutical Morphine Sulfate Product Portfolios and Specifications
 Table 130. Sun Pharmaceutical Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 131. Sun Pharmaceutical Main Business
 Table 132. Sun Pharmaceutical Latest Developments
 Table 133. Amneal Pharmaceuticals Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 134. Amneal Pharmaceuticals Morphine Sulfate Product Portfolios and Specifications
 Table 135. Amneal Pharmaceuticals Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 136. Amneal Pharmaceuticals Main Business
 Table 137. Amneal Pharmaceuticals Latest Developments
 Table 138. Rhodes Pharmaceuticals Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 139. Rhodes Pharmaceuticals Morphine Sulfate Product Portfolios and Specifications
 Table 140. Rhodes Pharmaceuticals Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 141. Rhodes Pharmaceuticals Main Business
 Table 142. Rhodes Pharmaceuticals Latest Developments
 Table 143. Purdue Pharma Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 144. Purdue Pharma Morphine Sulfate Product Portfolios and Specifications
 Table 145. Purdue Pharma Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 146. Purdue Pharma Main Business
 Table 147. Purdue Pharma Latest Developments
 Table 148. Sandoz Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 149. Sandoz Morphine Sulfate Product Portfolios and Specifications
 Table 150. Sandoz Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 151. Sandoz Main Business
 Table 152. Sandoz Latest Developments
 Table 153. Alcaliber Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 154. Alcaliber Morphine Sulfate Product Portfolios and Specifications
 Table 155. Alcaliber Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 156. Alcaliber Main Business
 Table 157. Alcaliber Latest Developments
 Table 158. Tasmanian Alkaloids Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 159. Tasmanian Alkaloids Morphine Sulfate Product Portfolios and Specifications
 Table 160. Tasmanian Alkaloids Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 161. Tasmanian Alkaloids Main Business
 Table 162. Tasmanian Alkaloids Latest Developments
 Table 163. G.L. Pharma Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 164. G.L. Pharma Morphine Sulfate Product Portfolios and Specifications
 Table 165. G.L. Pharma Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 166. G.L. Pharma Main Business
 Table 167. G.L. Pharma Latest Developments
 Table 168. Martindale Pharma Basic Information, Morphine Sulfate Manufacturing Base, Sales Area and Its Competitors
 Table 169. Martindale Pharma Morphine Sulfate Product Portfolios and Specifications
 Table 170. Martindale Pharma Morphine Sulfate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 171. Martindale Pharma Main Business
 Table 172. Martindale Pharma Latest Developments


List of Figures
 Figure 1. Picture of Morphine Sulfate
 Figure 2. Morphine Sulfate Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Morphine Sulfate Sales Growth Rate 2021-2032 (K Units)
 Figure 7. Global Morphine Sulfate Revenue Growth Rate 2021-2032 ($ millions)
 Figure 8. Morphine Sulfate Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
 Figure 9. Morphine Sulfate Sales Market Share by Country/Region (2025)
 Figure 10. Morphine Sulfate Sales Market Share by Country/Region (2021, 2025 & 2032)
 Figure 11. Product Picture of Immediate-Release (IR)
 Figure 12. Product Picture of Controlled-Release (CR)
 Figure 13. Product Picture of Sustained-Release (SR)
 Figure 14. Global Morphine Sulfate Sales Market Share by Type in 2026
 Figure 15. Global Morphine Sulfate Revenue Market Share by Type (2021-2026)
 Figure 16. Product Picture of <15 mg
 Figure 17. Product Picture of 15–30 mg
 Figure 18. Product Picture of 30–60 mg
 Figure 19. Product Picture of 60–100 mg
 Figure 20. Product Picture of >100 mg
 Figure 21. Global Morphine Sulfate Sales Market Share by Strength in 2026
 Figure 22. Global Morphine Sulfate Revenue Market Share by Strength (2021-2026)
 Figure 23. Morphine Sulfate Consumed in Acute Pain Management
 Figure 24. Global Morphine Sulfate Market: Acute Pain Management (2021-2026) & (K Units)
 Figure 25. Morphine Sulfate Consumed in Chronic Pain Management
 Figure 26. Global Morphine Sulfate Market: Chronic Pain Management (2021-2026) & (K Units)
 Figure 27. Global Morphine Sulfate Sale Market Share by Application (2025)
 Figure 28. Global Morphine Sulfate Revenue Market Share by Application in 2025
 Figure 29. Morphine Sulfate Sales by Company in 2025 (K Units)
 Figure 30. Global Morphine Sulfate Sales Market Share by Company in 2025
 Figure 31. Morphine Sulfate Revenue by Company in 2025 ($ millions)
 Figure 32. Global Morphine Sulfate Revenue Market Share by Company in 2025
 Figure 33. Global Morphine Sulfate Sales Market Share by Geographic Region (2021-2026)
 Figure 34. Global Morphine Sulfate Revenue Market Share by Geographic Region in 2025
 Figure 35. Americas Morphine Sulfate Sales 2021-2026 (K Units)
 Figure 36. Americas Morphine Sulfate Revenue 2021-2026 ($ millions)
 Figure 37. APAC Morphine Sulfate Sales 2021-2026 (K Units)
 Figure 38. APAC Morphine Sulfate Revenue 2021-2026 ($ millions)
 Figure 39. Europe Morphine Sulfate Sales 2021-2026 (K Units)
 Figure 40. Europe Morphine Sulfate Revenue 2021-2026 ($ millions)
 Figure 41. Middle East & Africa Morphine Sulfate Sales 2021-2026 (K Units)
 Figure 42. Middle East & Africa Morphine Sulfate Revenue 2021-2026 ($ millions)
 Figure 43. Americas Morphine Sulfate Sales Market Share by Country in 2025
 Figure 44. Americas Morphine Sulfate Revenue Market Share by Country (2021-2026)
 Figure 45. Americas Morphine Sulfate Sales Market Share by Type (2021-2026)
 Figure 46. Americas Morphine Sulfate Sales Market Share by Application (2021-2026)
 Figure 47. United States Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 48. Canada Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 49. Mexico Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 50. Brazil Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 51. APAC Morphine Sulfate Sales Market Share by Region in 2025
 Figure 52. APAC Morphine Sulfate Revenue Market Share by Region (2021-2026)
 Figure 53. APAC Morphine Sulfate Sales Market Share by Type (2021-2026)
 Figure 54. APAC Morphine Sulfate Sales Market Share by Application (2021-2026)
 Figure 55. China Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 56. Japan Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 57. South Korea Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 58. Southeast Asia Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 59. India Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 60. Australia Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 61. China Taiwan Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 62. Europe Morphine Sulfate Sales Market Share by Country in 2025
 Figure 63. Europe Morphine Sulfate Revenue Market Share by Country (2021-2026)
 Figure 64. Europe Morphine Sulfate Sales Market Share by Type (2021-2026)
 Figure 65. Europe Morphine Sulfate Sales Market Share by Application (2021-2026)
 Figure 66. Germany Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 67. France Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 68. UK Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 69. Italy Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 70. Russia Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 71. Middle East & Africa Morphine Sulfate Sales Market Share by Country (2021-2026)
 Figure 72. Middle East & Africa Morphine Sulfate Sales Market Share by Type (2021-2026)
 Figure 73. Middle East & Africa Morphine Sulfate Sales Market Share by Application (2021-2026)
 Figure 74. Egypt Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 75. South Africa Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 76. Israel Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 77. Turkey Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 78. GCC Countries Morphine Sulfate Revenue Growth 2021-2026 ($ millions)
 Figure 79. Manufacturing Cost Structure Analysis of Morphine Sulfate in 2026
 Figure 80. Manufacturing Process Analysis of Morphine Sulfate
 Figure 81. Industry Chain Structure of Morphine Sulfate
 Figure 82. Channels of Distribution
 Figure 83. Global Morphine Sulfate Sales Market Forecast by Region (2027-2032)
 Figure 84. Global Morphine Sulfate Revenue Market Share Forecast by Region (2027-2032)
 Figure 85. Global Morphine Sulfate Sales Market Share Forecast by Type (2027-2032)
 Figure 86. Global Morphine Sulfate Revenue Market Share Forecast by Type (2027-2032)
 Figure 87. Global Morphine Sulfate Sales Market Share Forecast by Application (2027-2032)
 Figure 88. Global Morphine Sulfate Revenue Market Share Forecast by Application (2027-2032)

Companies Mentioned

Jiangsu Nhwa Pharmaceutical

Humanwell Healthcare Group

Mallinckrodt Pharmaceuticals

Hikma Pharmaceuticals

Viatris

Pfizer

Fresenius Kabi

Hameln Pharma

Teva Pharmaceutical

Sun Pharmaceutical

Amneal Pharmaceuticals

Rhodes Pharmaceuticals

Purdue Pharma

Sandoz

Alcaliber

Tasmanian Alkaloids

G.L. Pharma

Martindale Pharma

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff